• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Vontier Expects Q2 Sales of $735M-$750M Vs $760.97M Est, Adj EPS of $0.67-$0.71 Vs $0.73 Est

    5/2/24 6:35:06 AM ET
    $VNT
    Industrial Machinery/Components
    Industrials
    Get the next $VNT alert in real time by email

    2024 Outlook

    • Total sales $3,040 to $3,100 million; Core sales growth +4 to 6%
    • Adjusted operating profit margin expansion of 80 to 110 basis points year-over-year
    • Adjusted diluted net earnings per share in the range of $3.00 to $3.15
    • Adjusted free cash flow conversion of ~90 to 100%

    Q2 2024 Outlook

    • Total sales $735 to $750 million; Core sales growth +2 to 4%
    • Adjusted operating profit margin expansion of 20 to 60 basis points year-over-year
    • Adjusted diluted net earnings per share in the range of $0.67 to $0.71
    Get the next $VNT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VNT

    DatePrice TargetRatingAnalyst
    12/12/2024$48.00Peer Perform → Outperform
    Wolfe Research
    12/10/2024$46.00 → $47.00Buy
    UBS
    8/20/2024Buy → Hold
    Argus
    1/11/2024$37.00 → $40.00Neutral → Buy
    BofA Securities
    9/27/2023$38.00Buy
    UBS
    12/12/2022$30.00 → $21.00Buy → Neutral
    BofA Securities
    12/1/2022Outperform → Peer Perform
    Wolfe Research
    2/18/2022$50.00 → $42.00Overweight
    Barclays
    More analyst ratings